柳药集团累计回购977.46万股 耗资1.8亿元

Summary of Key Points Core Viewpoint - Liu Pharmaceutical Group (603368.SH) has announced a share buyback program, indicating a commitment to enhancing shareholder value through capital return strategies [1] Group 1: Buyback Details - As of October 31, 2025, the company has repurchased a total of 9.7746 million shares [1] - The repurchased shares account for 2.46% of the company's total share capital, an increase of 0.42% compared to the previous announcement [1] - The highest price paid for the shares was 19.07 yuan per share, while the lowest price was 17.83 yuan per share [1] - The total amount spent on the buyback is 180 million yuan, excluding transaction fees [1]